Showing results (141-150 of 301) with videos related to
Sort By:
Pageof 31
Blood|July 4, 2013
Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumabEdmund A Rossi, David M Goldenberg, Rosana Michel, et al.Nuclear Medicine and Biology|September 23, 2003
Experimental therapy of disseminated B-Cell lymphoma xenografts with 213Bi-labeled anti-CD74Rosana B Michel, Adriane V Rosario, Martin W Brechbiel, et al.Proceedings of the National Academy of Sciences of the United States of America|April 26, 2006
Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targetingEdmund A Rossi, David M Goldenberg, Thomas M Cardillo, et al.Journal of Medicinal Chemistry|October 23, 2008
Antibody conjugates of 7-ethyl-10-hydroxycamptothecin (SN-38) for targeted cancer chemotherapySung-Ju Moon, Serengulam V Govindan, Thomas M Cardillo, et al.American Journal of Surgery|June 5, 2012
Anti-class II -DR humanized monoclonal antibody, IMMU-114, blocks allogeneic immune responseKyung Hwa Park, Tokihiko Sawada, Toru Murakami, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapyAlice P Taylor, Louis Osorio, Russell Craig, et al.Cancer Biotherapy & Radiopharmaceuticals|July 26, 2002
Use of galactosylated-streptavidin as a clearing agent with 111In-labeled, biotinylated antibodies to enhance tumor/non-tumor localization ratiosSerengulam V Govindan, Gary L Griffiths, Rosana B Michel, et al.Bioconjugate Chemistry|September 10, 2009
A new method to produce monoPEGylated dimeric cytokines shown with human interferon-α2bChien-Hsing Chang, Edmund A Rossi, Thomas M Cardillo, et al.Cancer Research|July 3, 2008
Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibodyRobert M Sharkey, Habibe Karacay, Samuel Litwin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Epratuzumab: targeting B-cell malignancies through CD22Morton Coleman, David M Goldenberg, Abby B Siegel, et al.Pageof 31